• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孤儿核受体DAX1由EWS/FLI1癌蛋白上调,在尤因肿瘤中高表达。

The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors.

作者信息

Mendiola Marta, Carrillo Jaime, García Eva, Lalli Enzo, Hernández Teresa, de Alava Enrique, Tirode Franck, Delattre Olivier, García-Miguel Purificación, López-Barea Fernando, Pestaña Angel, Alonso Javier

机构信息

Departamento de Biología Molecular y Celular del Cáncer, Instituto de Investigaciones Biomédicas A. Sols CSIC-UAM, 28029 Madrid, Spain.

出版信息

Int J Cancer. 2006 Mar 15;118(6):1381-9. doi: 10.1002/ijc.21578.

DOI:10.1002/ijc.21578
PMID:16206264
Abstract

The Ewing family of tumors harbors chromosomal translocations that join the N-terminal region of the EWS gene with the C-terminal region of several transcription factors of the ETS family, mainly FLI1, resulting in chimeric transcription factors that play a pivotal role in the pathogenesis of Ewing tumors. To identify downstream targets of the EWS/FLI1 fusion protein, we established 293 cells expressing constitutively either the chimeric EWS/FLI1 or wild type FLI1 proteins and used cDNA arrays to identify genes differentially regulated by EWS/FLI1. DAX1 (NR0B1), an unusual orphan nuclear receptor involved in gonadal development, sex determination and steroidogenesis, showed a consistent up-regulation by EWS/FLI1 oncoprotein, but not by wild type FLI1. Specific induction of DAX1 by EWS/FLI1 was confirmed in two independent cell systems with inducible expression of EWS/FLI1. We also analyzed the expression of DAX1 in Ewing tumors and derived cell lines, as well as in other nonrelated small round cell tumors. DAX1 was expressed in all Ewing tumor specimens analyzed, and in seven out of eight Ewing tumor cell lines, but not in any neuroblastoma or embryonal rhabdomyosarcoma. Furthermore, silencing of EWS/FLI1 by RNA interference in a Ewing tumor cell line markedly reduced the levels of DAX1 mRNA and protein, confirming that DAX1 up-regulation is dependent upon EWS/FLI1 expression. The high levels of DAX1 found in Ewing tumors and its potent transcriptional repressor activity suggest that the oncogenic effect of EWS/FLI1 may be mediated, at least in part, by the up-regulation of DAX1 expression.

摘要

尤因肿瘤家族存在染色体易位,该易位将EWS基因的N端区域与ETS家族的几种转录因子的C端区域连接起来,主要是FLI1,从而产生嵌合转录因子,这些因子在尤因肿瘤的发病机制中起关键作用。为了鉴定EWS/FLI1融合蛋白的下游靶点,我们建立了组成性表达嵌合EWS/FLI1或野生型FLI1蛋白的293细胞,并使用cDNA阵列来鉴定受EWS/FLI1差异调节的基因。DAX1(NR0B1)是一种参与性腺发育、性别决定和类固醇生成的不寻常孤儿核受体,显示出被EWS/FLI1癌蛋白持续上调,但不被野生型FLI1上调。在两个具有诱导性表达EWS/FLI1的独立细胞系统中证实了EWS/FLI1对DAX1的特异性诱导。我们还分析了DAX1在尤因肿瘤及其衍生细胞系以及其他不相关的小圆细胞肿瘤中的表达。DAX1在所分析的所有尤因肿瘤标本中以及在八个尤因肿瘤细胞系中的七个中表达,但在任何神经母细胞瘤或胚胎性横纹肌肉瘤中均不表达。此外,在一个尤因肿瘤细胞系中通过RNA干扰使EWS/FLI1沉默显著降低了DAX1 mRNA和蛋白水平,证实DAX1的上调依赖于EWS/FLI1的表达。在尤因肿瘤中发现的高水平DAX1及其强大的转录抑制活性表明,EWS/FLI1的致癌作用可能至少部分是由DAX1表达的上调介导的。

相似文献

1
The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors.孤儿核受体DAX1由EWS/FLI1癌蛋白上调,在尤因肿瘤中高表达。
Int J Cancer. 2006 Mar 15;118(6):1381-9. doi: 10.1002/ijc.21578.
2
DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.DAX1是EWS/FLI1癌蛋白的直接靶点,是尤因氏肿瘤细胞中细胞周期进程的主要调节因子。
Oncogene. 2008 Oct 9;27(46):6034-43. doi: 10.1038/onc.2008.203. Epub 2008 Jun 30.
3
NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma.在尤因肉瘤中,EWS/FLI介导的致癌表型需要NR0B1。
Mol Cancer Res. 2006 Nov;4(11):851-9. doi: 10.1158/1541-7786.MCR-06-0090.
4
Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.通过RNA干扰下调胆囊收缩素会损害尤因肉瘤的生长。
Clin Cancer Res. 2007 Apr 15;13(8):2429-40. doi: 10.1158/1078-0432.CCR-06-1762.
5
Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.通过抑制尤文肉瘤中的BET溴结构域靶向EWS-ETS转录程序。
Oncotarget. 2016 Jan 12;7(2):1451-63. doi: 10.18632/oncotarget.6385.
6
Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis.长链非编码RNA EWSAT1介导的基因抑制促进尤因肉瘤的肿瘤发生。
J Clin Invest. 2014 Dec;124(12):5275-90. doi: 10.1172/JCI72124. Epub 2014 Nov 17.
7
Proteasomal Degradation of the EWS-FLI1 Fusion Protein Is Regulated by a Single Lysine Residue.EWS-FLI1融合蛋白的蛋白酶体降解受单个赖氨酸残基调控。
J Biol Chem. 2016 Dec 23;291(52):26922-26933. doi: 10.1074/jbc.M116.752063. Epub 2016 Nov 8.
8
Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.编码转化生长因子-β II型受体的基因的抑制是EWS-FLI1癌蛋白的主要作用靶点。
Nat Genet. 1999 Oct;23(2):222-7. doi: 10.1038/13854.
9
Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.肿瘤特异性EWS-ETS融合基因诱导肌腱蛋白-C的产生。
Genes Chromosomes Cancer. 2003 Mar;36(3):224-32. doi: 10.1002/gcc.10153.
10
PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1.PI3K/AKT信号通路通过特异性蛋白1调节EWS/FLI1的转录表达。
Oncotarget. 2015 Oct 6;6(30):28895-910. doi: 10.18632/oncotarget.5000.

引用本文的文献

1
Druggable upregulated proteins in EWS-FLI-driven Ewing sarcoma as emerging new therapeutic targets.在EWS-FLI驱动的尤因肉瘤中可成药的上调蛋白作为新出现的治疗靶点。
Am J Transl Res. 2025 Mar 15;17(3):1580-1603. doi: 10.62347/YMEU1808. eCollection 2025.
2
Targeted inactivation of EWSR1 : : FLI1 gene in Ewing sarcoma via CRISPR/Cas9 driven by an Ewing-specific GGAA promoter.通过由尤因肉瘤特异性GGAA启动子驱动的CRISPR/Cas9对尤因肉瘤中的EWSR1::FLI1基因进行靶向失活。
Cancer Gene Ther. 2025 Apr;32(4):437-449. doi: 10.1038/s41417-025-00887-8. Epub 2025 Mar 15.
3
NR0B1 augments sorafenib resistance in hepatocellular carcinoma through promoting autophagy and inhibiting apoptosis.
NR0B1 通过促进自噬和抑制细胞凋亡增强肝癌对索拉非尼的耐药性。
Cancer Sci. 2024 Feb;115(2):465-476. doi: 10.1111/cas.16029. Epub 2023 Nov 22.
4
EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma.EWS/FLI1 的特征、激活、抑制、靶基因及在尤文肉瘤中的治疗机会。
Int J Mol Sci. 2023 Oct 14;24(20):15173. doi: 10.3390/ijms242015173.
5
CD44 Modulates Cell Migration and Invasion in Ewing Sarcoma Cells.CD44 调节尤文肉瘤细胞的迁移和侵袭。
Int J Mol Sci. 2023 Jul 21;24(14):11774. doi: 10.3390/ijms241411774.
6
Investigation of Flavonoid Scaffolds as DAX1 Inhibitors against Ewing Sarcoma through Pharmacoinformatic and Dynamic Simulation Studies.通过基于药物的计算和动态模拟研究调查黄酮类支架作为 DAX1 抑制剂对尤文肉瘤的作用。
Int J Mol Sci. 2023 May 26;24(11):9332. doi: 10.3390/ijms24119332.
7
Screening for DAX1/EWS-FLI1 functional inhibitors identified dihydroorotate dehydrogenase as a therapeutic target for Ewing's sarcoma.筛选 DAX1/EWS-FLI1 功能抑制剂发现二氢乳清酸脱氢酶是尤文肉瘤的治疗靶点。
Cancer Med. 2023 Apr;12(8):9802-9814. doi: 10.1002/cam4.5741. Epub 2023 Feb 24.
8
Epigenetic and Transcriptional Signaling in Ewing Sarcoma-Disease Etiology and Therapeutic Opportunities.尤因肉瘤中的表观遗传和转录信号——疾病病因与治疗机遇
Biomedicines. 2022 Jun 5;10(6):1325. doi: 10.3390/biomedicines10061325.
9
One oncogene, several vulnerabilities: EWS/FLI targeted therapies for Ewing sarcoma.一个癌基因,多种脆弱性:尤因肉瘤的EWS/FLI靶向疗法
J Bone Oncol. 2021 Dec 1;31:100404. doi: 10.1016/j.jbo.2021.100404. eCollection 2021 Dec.
10
Therapeutic Potential of Inactivation by CRISPR/Cas9 in Ewing Sarcoma.CRISPR/Cas9介导的失活在尤因肉瘤中的治疗潜力
Cancers (Basel). 2021 Jul 27;13(15):3783. doi: 10.3390/cancers13153783.